Israel Englander Sarepta Therapeutics, Inc. Call Options Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $4.73 Million - $7.15 Million	-50,500 Reduced 43.2%	66,400 $8.6 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $7.08 Million - $13.1 Million	105,200 Added 899.15%	116,900 $11.3 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $6.74 Million - $9.95 Million	-63,300 Reduced 84.4%	11,700 $1.34 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $8.81 Million - $11.7 Million	75,000 New	75,000 $10.3 Million

548

85.7M

3.67M

1.73M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.2B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.